Literature DB >> 17127096

Brain CHIP: removing the culprits in neurodegenerative disease.

Chad A Dickey1, Cam Patterson, Dennis Dickson, Leonard Petrucelli.   

Abstract

A factor that is common to the most-frequent neurodegenerative diseases is the accumulation of abnormal proteins that are associated with cellular dysfunction. Contrary to years of speculation, recent evidence suggests that soluble intermediates--not the visible pathological aggregates associated with disease--are the cause of neurotoxicity. These findings suggest that aggregate formation might be an adaptive stress response that is facilitated by neuronal protein triage molecules. In particular, the molecular co-chaperone CHIP (C terminus of HSC70-interacting protein) has been linked to several of these disorders, serving as a crucial catalyst for the ubiquitination of several heat shock protein (HSP)70 client proteins that are involved in neurodegenerative disease. Therefore, understanding the mechanisms that are involved in CHIP-mediated protein trafficking might provide invaluable clues to neuronal function, both in normal and diseased conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127096     DOI: 10.1016/j.molmed.2006.11.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  47 in total

Review 1.  Knock-out and transgenic mouse models of tauopathies.

Authors:  Franziska Denk; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-22       Impact factor: 4.673

2.  The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins.

Authors:  Amit Mishra; Swetha K Godavarthi; Megha Maheshwari; Anand Goswami; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

3.  Endoplasmic reticulum protein quality control is determined by cooperative interactions between Hsp/c70 protein and the CHIP E3 ligase.

Authors:  Yoshihiro Matsumura; Juro Sakai; William R Skach
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  The E3 ubiquitin ligase UBE3C enhances proteasome processivity by ubiquitinating partially proteolyzed substrates.

Authors:  Bernard W Chu; Kyle M Kovary; Johan Guillaume; Ling-chun Chen; Mary N Teruel; Thomas J Wandless
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

5.  Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP).

Authors:  Le Wang; Yi-Tong Liu; Rui Hao; Lei Chen; Zhijie Chang; Hong-Rui Wang; Zhi-Xin Wang; Jia-Wei Wu
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

6.  E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.

Authors:  Peter Tsvetkov; Yaarit Adamovich; Evan Elliott; Yosef Shaul
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

7.  C-terminus of heat shock cognate 70 interacting protein increases following stroke and impairs survival against acute oxidative stress.

Authors:  Jeannette N Stankowski; Stephanie L H Zeiger; Evan L Cohen; Donald B DeFranco; Jiyang Cai; BethAnn McLaughlin
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

8.  Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.

Authors:  Xinyue Zhang; Chengyuan Li; Stephen C Fowler; Zheng Zhang; Brian S J Blagg; Rick T Dobrowsky
Journal:  ACS Chem Neurosci       Date:  2017-11-09       Impact factor: 4.418

9.  CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins.

Authors:  Yoshihiro Morishima; Adrienne M Wang; Zhigang Yu; William B Pratt; Yoichi Osawa; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-09-10       Impact factor: 6.150

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.